Matterhorn, Switzerland
RSQBlog_FINAL.png

An Update on the US Generic Drug Pricing Dilemma

In August 2017, we wrote a piece about pricing pressure in the US generic drugs market. We focused on the acceleration in generic drug approvals, which is only one of the factors in today's deflationary environment. At the time, we did not believe we would see pricing equilibrium in the near-term under the current regulatory and business conditions, and predicted that prices for generic drugs would continue to decline until manufacturers gained negotiating leverage.

Posted by Daeil Cha on Aug 23, 2018 3:47:32 PM

Topics: From the Desk of Daeil Cha, Pharmaceutical

Read More
Comments Welcome